Nuclear Medicine Industry The global nuclear medicine market size was estimated at USD 17.77 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 10.16% from 2025 to 2030. The industry is experiencing growth due to the presence of a strong and advancing product pipeline, along with supportive government initiatives aimed at enhancing access to nuclear...

India Radioligand Therapy (RLT) Market Overview Radioligand therapy (RLT) is rapidly gaining ground as a revolutionary cancer treatment modality, particularly in nuclear medicine and oncology. In India, the radioligand therapy market is witnessing accelerated growth due to rising cancer prevalence, increasing adoption of personalized medicine, and growing investments in advanced nuclear...

Radioligand Therapy Market Overview The Radioligand Therapy (RLT) market is emerging as a transformative segment in precision oncology and nuclear medicine. Radioligand therapy is a targeted cancer treatment that combines a radioactive isotope with a ligand to deliver cytotoxic radiation directly to cancer cells while sparing surrounding healthy tissues. This innovative approach has...

Radioligand Therapy (RLT): A Targeted Breakthrough in Cancer Treatment Radioligand Therapy (RLT) is an innovative and highly targeted form of cancer treatment that combines the precision of molecular medicine with the power of radiation therapy. Unlike traditional cancer treatments that may affect both healthy and malignant cells, RLT offers a focused approach by delivering radioactive...